Metastatic Colorectal Cancers Unknown Status Phase 2 Trials for Irinotecan (DB00762)

Also known as: Colorectal Cancer Metastatic / Metastatic Colorectal Cancer / Metastatic Colorectal Cancer (MCRC) / Cancer - Metastatic Colorectal / Colorectal Cancer, Metastatic

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyTreatment
NCT00931840A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal CarcinomaTreatment
NCT01144195A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line ChemotherapyTreatment
NCT02216487Trial of FOLF(HA)Iri With Cetuximab in mCRCTreatment